The FDA and vaccine producers assert their confidence in the safety of doses designed to target Omicron subvariants. Now, the new Covid boosters are set to roll out without human testing.
This week, the Food and Drug Administration is anticipated to approve new Covid-19 booster shots without using data from a study demonstrating whether the shots were safe and effective in patients, a necessary component of its typical decision-making process.
The FDA will not have finished testing th...
